Osama Moussa1, Maddalena Ardissino2,3, Silvia Muttoni4, Ara Faraj4, Alice Tang4, Omar Khan5, Peter Collins6, Usman Jaffer7, Sanjay Purkayastha1. 1. Department of Surgery and Cancer, Imperial College London, Praed Street, London, W2 1NY, UK. 2. Department of Medicine, Imperial College London, London, SW7 2AZ, UK. ma5713@ic.ac.uk. 3. Academic Unit, Imperial College London School of Medicine, Exhibition Road, London, SW7 2AZ, UK. ma5713@ic.ac.uk. 4. Department of Medicine, Imperial College London, London, SW7 2AZ, UK. 5. Department of Upper GI and Bariatric Surgery, St George's University of London, London, SW17 0RE, UK. 6. Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, SW3 6NP, UK. 7. Department of Vascular Surgery, St Mary's Hospital, Imperial College NHS Trust, Praed Street, London, W2 1NY, UK.
Abstract
BACKGROUND AND AIMS: Patients with obesity are at high risk of suffering from arterial and venous peripheral vascular disease (PVD). Bariatric surgery is an effective strategy to achieve weight reduction for patients with obesity. The long-term impact of bariatric surgery on obesity-related morbidity is subject to increasing research interest. This study aimed to ascertain the impact of bariatric surgery on the long-term occurrence of PVD in patients with obesity. METHODS: The study population was extracted from the Clinical Practice Research Datalink, a nation-wide database containing primary and secondary care records of consenting patients. The intervention cohort was 2959 patients who had undergone bariatric surgery during follow-up; their controls were 2959 propensity-score-matched counterparts. The primary endpoint was development of any PVD: arterial or venous. Secondary endpoints were incident peripheral arterial disease alone, incident peripheral venous disease alone. RESULTS: Three hundred forty-six patients suffered a primary endpoint during follow-up. Bariatric surgery did not improve peripheral vascular disease rates as a whole, but it was associated with significantly lower event rates of arterial disease (HR = 0.560, 95%CI 0.327-0.959, p = 0.035) but higher event rates of venous disease (HR = 1.685, 95%CI 1.256-2.262, p < 0.001). CONCLUSIONS: Bariatric surgery was associated with significantly reduced long-term occurrence of arterial disease but increased occurrence of venous disease in patients with obesity.
BACKGROUND AND AIMS: Patients with obesity are at high risk of suffering from arterial and venous peripheral vascular disease (PVD). Bariatric surgery is an effective strategy to achieve weight reduction for patients with obesity. The long-term impact of bariatric surgery on obesity-related morbidity is subject to increasing research interest. This study aimed to ascertain the impact of bariatric surgery on the long-term occurrence of PVD in patients with obesity. METHODS: The study population was extracted from the Clinical Practice Research Datalink, a nation-wide database containing primary and secondary care records of consenting patients. The intervention cohort was 2959 patients who had undergone bariatric surgery during follow-up; their controls were 2959 propensity-score-matched counterparts. The primary endpoint was development of any PVD: arterial or venous. Secondary endpoints were incident peripheral arterial disease alone, incident peripheral venous disease alone. RESULTS: Three hundred forty-six patients suffered a primary endpoint during follow-up. Bariatric surgery did not improve peripheral vascular disease rates as a whole, but it was associated with significantly lower event rates of arterial disease (HR = 0.560, 95%CI 0.327-0.959, p = 0.035) but higher event rates of venous disease (HR = 1.685, 95%CI 1.256-2.262, p < 0.001). CONCLUSIONS: Bariatric surgery was associated with significantly reduced long-term occurrence of arterial disease but increased occurrence of venous disease in patients with obesity.
Authors: Paul Poirier; Marc-André Cornier; Theodore Mazzone; Sasha Stiles; Susan Cummings; Samuel Klein; Peter A McCullough; Christine Ren Fielding; Barry A Franklin Journal: Circulation Date: 2011-03-14 Impact factor: 29.690
Authors: Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino Journal: Lancet Date: 2015-09-05 Impact factor: 79.321
Authors: Reza Aghamohammadzadeh; Adam S Greenstein; Rahul Yadav; Maria Jeziorska; Salam Hama; Fardad Soltani; Phil W Pemberton; Basil Ammori; Rayaz A Malik; Handrean Soran; Anthony M Heagerty Journal: J Am Coll Cardiol Date: 2013-05-09 Impact factor: 24.094
Authors: Alan Robson Trigueiro de Sousa; Wilson Rodrigues Freitas Junior; Eduardo Araujo Perez; Elias Jirjoss Ilias; Anderson Soares Silva; Vera Lucia Santos Alves; João Pedro Ribeiro Afonso; Miriã Cândida Oliveira; Adriano Luís Fonseca; Marcos Mota da Silva; Maria Eduarda Moreira Lino; Manoel Carneiro Oliveira Junior; Rodolfo Paula Vieira; Wilson José Sena Pedro; André Luis Lacerda Bachi; Giuseppe Insalaco; Carlos Alberto Malheiros; Luis Vicente Franco Oliveira Journal: Obes Surg Date: 2021-09-23 Impact factor: 4.129